4DMedical

4DMedical EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of 4DMedical (4DX.AX) as of Oct 17, 2026 is -57.46 M AUD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -42.17 M AUD — a change of 36.24% (lower).

EBITDA

-57.46 MAUD

YoY

36.24%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of 4DMedical is 2026 -57.46 M AUD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of 4DMedical was 2025 -42.17 M AUD. It decreases by 36.24% lower compared to the previous year.

The 4DMedical EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
-6.91 M AUD
Jan 1, 2020
-15.38 M AUD
Jan 1, 2021
-18.01 M AUD
Jan 1, 2022
-35.25 M AUD
Jan 1, 2023
-28.09 M AUD
Jan 1, 2024
-23.90 M AUD
Jan 1, 2025
-42.17 M AUD
Jan 1, 2026
-57.46 M AUD
The 4DMedical EBITDA history
YEAREBITDAYoY
-57.46 MAUD+36.24%
-42.17 MAUD+76.45%
-23.90 MAUD-14.91%
-28.09 MAUD-20.33%
-35.25 MAUD+95.79%
-18.01 MAUD+17.10%
-15.38 MAUD+122.42%
-6.91 MAUD+38.02%
-5.01 MAUD+10.04%
-4.55 MAUD+432.53%
-854,869.00AUD+348.64%
-190,548.00AUD0.00%
-190,548.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

4DMedical Stock analysis

What does 4DMedical do? 4DMedical Ltd, headquartered in Melbourne, Australia, operates in the Health Care sector, specializing in four-dimensional lung imaging technology. The company commercializes its patented XV Technology, enabling physicians to assess regional airflow and identify respiratory issues earlier through its FDA-cleared XV Lung Ventilation Analysis Software (XV LVA) and CT LVAS. These solutions, delivered via a SaaS model, utilize existing hospital imaging equipment or the company's XV Scanner, with commercial rollout initiated through partnerships like I-MED Radiology Network, serving approximately 250 clinics nationwide. 4DMedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about 4DMedical stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of 4DMedical is -57.46 M AUD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of 4DMedical changed from -42.17 M AUD to -57.46 M AUD, representing a 36.24% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) 4DMedical since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s 4DMedical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — 4DMedical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — 4DMedical